Ancora Advisors LLC - PHOENIX BIOTECH ACQUISITION ownership

PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K105. A total of 55 filers reported holding PHOENIX BIOTECH ACQUISITION in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Ancora Advisors LLC ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q1 2022$50,0005,0000.00%
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q2 2022
NameSharesValueWeighting ↓
Atalaya Capital Management LP 450,000$4,514,0000.53%
Lynwood Capital Management Inc. 34,615$347,0000.39%
Sage Rock Capital Management LP 183,998$1,844,0000.36%
HGC Investment Management Inc. 1,000,000$10,013,0000.31%
MMCAP International Inc. SPC 370,000$3,707,0000.30%
Context Capital Management, LLC 400,000$4,008,0000.29%
Bulldog Investors, LLP 99,064$993,0000.27%
First Trust Capital Management L.P. 352,600$3,533,0000.25%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 1,029,262$10,323,0000.24%
NEXPOINT ASSET MANAGEMENT, L.P. 217,482$2,181,0000.19%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders